381 related articles for article (PubMed ID: 20724119)
1. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
Welte T; Pletz MW
Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Maclayton DO; Hall RG
Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
[TBL] [Abstract][Full Text] [Related]
3. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
Scheinfeld N
J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Segarra-Newnham M; Church TJ
Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021
[TBL] [Abstract][Full Text] [Related]
5. New therapy options for MRSA with respiratory infection/pneumonia.
Ramirez P; Fernández-Barat L; Torres A
Curr Opin Infect Dis; 2012 Apr; 25(2):159-65. PubMed ID: 22248980
[TBL] [Abstract][Full Text] [Related]
6. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.
Gould IM; David MZ; Esposito S; Garau J; Lina G; Mazzei T; Peters G
Int J Antimicrob Agents; 2012 Feb; 39(2):96-104. PubMed ID: 22196394
[TBL] [Abstract][Full Text] [Related]
7. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
8. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
9. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
[TBL] [Abstract][Full Text] [Related]
10. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for nosocomial pneumonia due to MRSA.
Niederman MS
J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
[TBL] [Abstract][Full Text] [Related]
12. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Micek ST
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
[TBL] [Abstract][Full Text] [Related]
13. New treatments for methicillin-resistant Staphylococcus aureus.
Stryjewski ME; Corey GR
Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
[TBL] [Abstract][Full Text] [Related]
14. Treatment of infections due to resistant Staphylococcus aureus.
Anstead GM; Cadena J; Javeri H
Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus.
Ferrara AM
Int J Antimicrob Agents; 2007 Jul; 30(1):19-24. PubMed ID: 17475449
[TBL] [Abstract][Full Text] [Related]
16. Management of methicillin-resistant Staphylococcus aureus pneumonia.
Luna CM; Boyeras Navarro ID
Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
Tverdek FP; Crank CW; Segreti J
Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944
[TBL] [Abstract][Full Text] [Related]
18. Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates.
Campanile F; Borbone S; Perez M; Bongiorno D; Cafiso V; Bertuccio T; Purrello S; Nicolosi D; Scuderi C; Stefani S
Int J Antimicrob Agents; 2010 Nov; 36(5):415-9. PubMed ID: 20727722
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
[TBL] [Abstract][Full Text] [Related]
20. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Culos KA; Cannon JP; Grim SA
Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
